The recent identification of ADAM22 compound heterozygous mutations in a patient with severe encephalopathy and epilepsy, who inherited the mutations by healthy parents, supports the hypothesis that ADAM22 may primarily be a recessive disease gene [37]. The gene discussed is ADAM22; the disease is epilepsy.